Therapy Areas: Diabetes
10 January 2019 - - US-based drug developer AgeX Therapeutics, Inc. (NYSE American: AGE) has published data relating to its cell therapy product candidate AgeX-BAT1 for Type II diabetes and obesity in...
10 January 2019 - - US-based biotechnology company NeuroBo Pharmaceuticals, Inc plans to initiate a Phase III trial to evaluate the efficacy of its lead drug, NB-01, in diabetic neuropathic pain in ea...
10 January 2019 - Pharmaceutical company Oramed Pharmaceuticals Inc (NASDAQ:ORMP) (TASE:ORMP) reported on Wednesday the receipt of a milestone payment of USD3m for ORMD-0801 under a prior license and ...
8 January 2019 - - US-based RNAi-based therapeutics developer Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) has dosed the first subjects in a Phase 1 clinical study of ARO-ANG3, an RNAi-based investig...
8 January 2019 - - Michael Shetzline, M.D., Ph.D., will join US-based biotechnology company Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) as chief medical officer, senior vice president and head ...
4 January 2019 - - US-based pharmaceutical company Merck (NYSE: MRK) has exercised its option to license NGM313, an investigational monoclonal antibody agonist of the β-Klotho/FGFR1c receptor com...